Interactive Brokers Adds Multi-Monitor Support and More to IBKR Desktop Trading Platform
Streamlined Design with Powerful Trading Technology
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced updates to IBKR Desktop, a next-generation trading platform for investors who demand simplicity but value Interactive Brokers’ advanced technology. With no platform fees and a user-friendly interface packed with advanced features, clients can easily facilitate simple trades across asset classes and complex order types. The platform is designed to be intuitive and easy to navigate, making it suitable for experienced traders and novice investors.
“IBKR Desktop is a powerful, intuitive platform designed for traders and investors of all experience levels. Whether you’re just getting started or managing advanced trading strategies, IBKR Desktop provides the tools, research, and customization needed to trade with confidence,” said Steve Sanders, Executive Vice President of Marketing and Product Development at Interactive Brokers. “These enhancements reflect our ongoing commitment to deliver a world-class trading experience across an advanced and easy-to-use platform.”
With IBKR Desktop, clients can trade products from over 160 global exchanges, including stocks, options, futures, currencies, bonds, and funds, from a single unified platform and access popular and exclusive tools that prioritize customization and flexibility. IBKR Desktop offers superior order execution, competitive pricing, and an extensive suite of global investment products designed to optimize trading and enhance investment strategies.
Power meets simplicity in the IBKR Desktop platform, allowing clients to feel at ease and in control of their trading experience. Recent updates include:
- Multi-Monitor Support: View multiple IBKR Desktop monitors by detaching layout screens. Link panels across IBKR Desktop screens to view selected products on multiple screens.
- ForecastTrader: Use forecast contracts to trade predictions on political, economic, and climate events. The availability of forecast contracts may vary depending on region.
- Overnight Trading Hours Support: Trade over 10,000 US stocks, ETFs, and US Equity Index futures and options around the clock to react immediately to market-moving news in IBKR Desktop. This service was already available across other trading platforms.
- Screeners: Use MultiSort to find stocks that align with trading strategies across a universe of over 70,000 global stocks, and standard screeners to quickly scan markets to return top securities based on region, product, sector, and factor criteria.
- Alerts and Notifications: Enable sounds for price alerts and trade notifications.
For additional information, please visit:
US and countries served by IB LLC: IBKR Desktop - US and LLC
Canada: IBKR Desktop - Canada
United Kingdom: IBKR Desktop - UK
Europe: IBKR Desktop - Europe
Hong Kong: IBKR Desktop - HK
Singapore: IBKR Desktop - Singapore
Australia: IBKR Desktop - Australia
India: IBKR Desktop - India
Japan: IBKR Desktop - Japan
The best-informed investors choose Interactive Brokers
About Interactive Brokers Group, Inc.:
Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities, foreign exchange, and forecast contracts around the clock on over 160 markets in numerous countries and currencies from a single unified platform to clients worldwide. We serve individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation have enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. Interactive Brokers has consistently earned recognition as a top broker, garnering multiple awards and accolades from respected industry sources such as Barron's, Investopedia, Stockbrokers.com, and many others.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402620502/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forrester Announces The EMEA Recipients Of Its 2025 Customer-Obsessed Enterprise Award21.5.2025 11:00:00 CEST | Press release
This year’s award winners, Brenntag and e&, will be recognised at CX Summit EMEA Forrester (Nasdaq: FORR) today announced that Brenntag and e& are the winners of its 2025 Customer-Obsessed Enterprise Award for Europe, Middle East, and Africa (EMEA). The award recognises organisations that place their customers at the centre of their leadership, strategy, and operations to drive business outcomes, including building sustainable growth, customer loyalty, and employee engagement. Both recipients will be celebrated at CX Summit EMEA, a leading event for CX, B2C marketing, and digital leaders to learn best practices and receive actionable advice, being held in London and digitally from 2–4 June 2025. This year’s recognition highlights two firms: one leading the charge on customer obsession in the B2B sector and the other in B2C. Brenntag, a global leader in chemicals and ingredients distribution, has been selected for embedding customer obsession into its B2B operations spanning 72 countrie
Legora Attracts $80 Million Series B Funding as Top Global Law Firms and Legal Teams Rush to Adopt Its Collaborative AI21.5.2025 10:00:00 CEST | Press release
Legora, the collaborative AI platform for lawyers, hits $675 million valuation with $80 million Series B funding round. With 250 clients in 20 markets, Legora counts prestigious global law firms like Cleary Gottlieb, Bird & Bird, Goodwin, Mannheimer Swartling, and Perez-Llorca as clients. In addition to prominence in the UK and wider Europe, the company has made significant inroads in the US with the opening of a New York office in April 2025. This latest funding is led by ICONIQ and General Catalyst, alongside existing investors Redpoint Ventures, Benchmark, and Y Combinator. Today, Legora announces an $80 million funding round led by ICONIQ and General Catalyst, with continued support from existing investors Redpoint Ventures, Benchmark, and Y Combinator. This latest round is a strong endorsement of Legora’s product quality, velocity and the remarkable traction it has achieved globally—underscored by its rapid progression from inception to Series B in under two years. The deal comes
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films21.5.2025 10:00:00 CEST | Press release
The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) hereby notifies that it has obtained judgments in its favor (hereinafter referred to as “the Judgments”) from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as “Kuraray Europe”), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled “Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany.” This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol’ The Wedge Acoustic Shadeband” (hereinafter collectively referred to as “Kuraray Products”) infringe European Patent No.
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom